Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AACR MEETING INCLUDES NUMEROUS PAPERS ON SKY DIAGNOSTIC TOOL.


Spectral karyotyping Karyotyping
A laboratory test used to study an individual's chromosome make-up. Chromosomes are separated from cells, stained, and arranged in order from largest to smallest so that their number and structure can be studied under a microscope.
 (SKY) was a key diagnostic tool in eight papers presented at the recent annual meeting of the American Association for Cancer Research Wikipedia is not the place for advertisement or self-advertising.

The American Association for Cancer Research (AACR) is an organization based in Philadelphia, Pennsylvania, that focuses on all aspects of cancer research including basic, clinical and translational
 (AACR AACR American Association for Cancer Research
AACR Anglo-American Cataloging Rules
AACR Australasian Association of Cancer Registries
AACR African Armed Conflicts Resolved
) in Philadelphia, PA. SKY, developed by Applied Spectral Imaging, is a medical imaging technology with wide applications in both health care and other unrelated fields. SKY displays all chromosomes in different colors which lets cytogeneticists more accurately identify translocations, marker chromosomes and other aberrations.

In the papers presented at the AACR meeting, researchers demonstrated that SKY had two advantages that may lead to more effective and earlier diagnosis of various types of cancer. First, SKY let researchers survey an entire tumor genome in a single experiment. Also, SKY identified tumor specific chromosomal aberrations with unprecedented accuracy. This combination of speed and accuracy in cancer diagnosis suggests that SKY may pinpoint ways to improve existing cancer therapies.

"We are excited that SKY is proving itself to be a reliable diagnostic tool in molecular cytogenetics," said H. Laurence Shaw, MD, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Applied Spectral Imaging. "In the near future, we hope to see the same success extended to other fields," he added.

SKY is based on SpectraCube, an award-winning imaging technology developed by Applied Spectral Imaging. SpectraCube's power is its ability to display information that conventional imaging systems cannot detect. Applied Spectral Imaging believes that this breakthrough represents a new modality in medical imaging with an impact similar to PCR PCR polymerase chain reaction.

PCR
abbr.
polymerase chain reaction


Polymerase chain reaction (PCR) 
 and flow cytometry flow cytometry (flōˑ sī·tˑ·m  in their respective fields. Along with cytogenetics cytogenetics /cy·to·ge·net·ics/ (-je-net´iks) the branch of genetics devoted to cellular constituents concerned in heredity, i.e. chromosomes. , other applications include pathology, microbiology, hematology, ophthalmology, gene-based cancer detection systems and catheter-based endoscopic en·do·scope  
n.
An instrument for examining visually the interior of a bodily canal or a hollow organ such as the colon, bladder, or stomach.



en
 systems. Applied Spectral Imaging is interested in corporate alliances in research and development as well as licensing rights to Applied Spectral Imaging technology.

Applied Spectral Imaging first launched SKY in 1995. SpectraCube was awarded the "European IT Grand Prize" in 1997 and the "Photonics Circle of Excellence Award" in 1995. Applied Spectral Imaging has offices in Migdal Ha'Emek (Israel), Carlsbad, CA, (US), and Mannheim (Germany). With its first marketed product, Applied Spectral Imaging is the world's leader in the 24-color imaging system market in the field of molecular cytogenetics.

For more information, call +972 6 6547567.
COPYRIGHT 1999 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Biotech Equipment Update
Date:Jun 1, 1999
Words:353
Previous Article:LUNAR INTRODUCES ACHILLES EXPRESS ULTRASONOMETER.
Next Article:ORTHOFIX ACQUIRES FIRM FOCUSED ON TISSUE GROWTH STIMULATION.



Related Articles
New anticancer strategy targets gene.
EntreMed Research emphasizing low-dose cancer therapy featured at cancer research meeting.
Cell Therapeutics reports discovery of novel gene target for cancer drug development.
Calendar.
AACR meeting explores new tools for cancer research.
New CGH products.
Molecular biomarkers predicting efficacy of cancer therapy highlighted.
Knowledge without boundaries; organizing information for the future.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles